Why We Need to Invest in Women Leading Cancer Research
Listen to a Conversation with Dr. Nora Disis in Support of the American Cancer Society’s ResearcHERs Campaign
Why do we need more women leading cancer research? What specific challenges do women face and what are some strategies we can use to accelerate our careers in research & development? Is academia broken?
These are a few of the questions Eileen Faucher and Nora Disis discussed in their Linkedin Live conversation in April of 2022, in support of the American Cancer Society’s ResearcHERs campaign. To learn more about this campaign and how you can get involved, go here.
Dr. Disis is a renowned cancer researcher at the University of Washington, and one of the investigators who discovered HER-2/neu to be a tumor-specific marker. She currently directs the UW Medicine Cancer Vaccine Institute and serves as the Associate Dean of Translational Health Science and the Editor-in-Chief of JAMA Oncology.
About The Author
Dr. Eileen Faucher is the Founder & Principal of Brass Tacks Health, a boutique consulting team that provides biotech and pharma clients with original insights into their competitive clinical development landscapes, grounded in perspectives that reflect the diversity of the patient populations being served. We guide clients in how to build their competitive advantage by tapping into their organization's commitment to advancing health equity and inclusion.